Related Experiment Video
Updated: Aug 8, 2025

In Vitro Stimulation and Visualization of Extracellular Trap Release in Differentiated Human Monocyte-derived Macrophages
Published on: November 1, 2019
Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and
Puneetpal Singh1, Nitin Kumar1, Monica Singh1
1Division of Molecular Genetics, Department of Human Genetics, Punjabi University, Patiala 147002, India.
Insights
Atherosclerosis involves arterial plaque buildup, leading to ischemia. This review explores how neutrophil extracellular traps (NETs) and NLRP3 inflammasome activation drive atherosclerosis, inflammation, and atherothrombosis.
Area of Science:
- Cardiovascular Science
- Immunology
- Pathology
Background:
- Atherosclerosis, a leading cause of global morbidity and mortality, involves arterial plaque formation and blood flow blockage.
- It is driven by pro-inflammatory and pro-coagulatory factors, significantly impacting cardiovascular, rheumatological, and neurological health.
- Neutrophil extracellular traps (NETs) and NLRP3 inflammasome activation are key pathways implicated in its progression.
Purpose of the Study:
- To review the significant roles of NET formation and NLRP3 inflammasome activation in atherosclerosis.
- To elucidate the individual and combined contributions of these processes to inflammation and atherothrombosis.
Main Methods:
- Literature review focusing on the molecular mechanisms of NETs and NLRP3 inflammasome in atherosclerosis.
- Analysis of studies investigating the interplay between these pathways and atherosclerotic plaque development.
- Synthesis of current understanding of their impact on atherothrombosis.
Main Results:
- NET formation contributes to plaque instability and thrombosis.
- NLRP3 inflammasome activation promotes inflammation and cellular dysfunction within atherosclerotic lesions.
- The synergistic action of NETs and NLRP3 inflammasome exacerbates atherosclerotic progression and adverse outcomes.
Conclusions:
- NETs and NLRP3 inflammasome are critical mediators in atherosclerosis, inflammation, and atherothrombosis.
- Targeting these pathways may offer novel therapeutic strategies for managing atherosclerosis.
- Further research is warranted to fully understand their collaborative impact and therapeutic potential.
Abstract:
Atherosclerosis is the formation of plaque within arteries due to overt assemblage of fats, cholesterol and fibrous material causing a blockage of the free flow of blood leading to ischemia. It is harshly impinging on health statistics worldwide because of being principal cause of high morbidity and mortality for several diseases including rheumatological, heart and brain disorders. Atherosclerosis is perpetuated by pro-inflammatory and exacerbated by pro-coagulatory mediators. Besides several other pathways, the formation of neutrophil extracellular traps (NETs) and the activation of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome contribute significantly to the initiation and propagation of atherosclerotic plaque for its worst outcomes. The present review highlights the contribution of these two disturbing processes in atherosclerosis, inflammation and atherothrombosis in their individual as well as collaborative manner.
More Related Videos
06:52Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...